Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic Profiling of Peripheral T-cell Lymphoma

ABSTRACT: Genomic Profiling of Peripheral T-cell Lymphoma

PROVIDER: PRJNA601013 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Genomic Profiling of Peripheral T-cell Lymphoma

Project description:Genomic Profiling of Peripheral T-cell Lymphoma

| PRJNA601013 | ENA

Genomic Profiling of Peripheral T-cell Lymphoma

Project description:Genomic Profiling of Peripheral T-cell Lymphoma

| PRJNA601014 | ENA

Peripheral T-cell Lymphoma gene expression profiling

Project description:Peripheral T-cell Lymphoma gene expression profiling

| PRJNA548345 | ENA

Peripheral T-cell Lymphoma gene expression profiling

Project description:Peripheral T-cell Lymphoma cases along with normal T-cells were subjected to gene expression profiling by means of a DASL array. The cases included both PTCL/NOS and Lennert Lymphoma.

2019-09-19 | GSE132550 | GEO

Gene expression profiling of peripheral T-cell lymphoma including gamma delta T-cell lymphoma

Project description:We performed gene expression profiling in 34 peripheral T-cell lymphoma, including 7 cases of gamma delta T-cell lymphoma to identify a unique T-cell receptor signature gene set for classification of gamma delta T-cell lymphoma and alpha beta T-cell lymphoma.

2008-10-15 | GSE11946 | GEO

Identification of multiple subclones in Peripheral T-cell Lymphoma, Not Otherwise Specified with genomic aberrations

Project description:Genomic aberration profiles of Peripheral T-cell Lymphoma, Not Otherwise specified (clinical samples)

2012-05-31 | E-MTAB-998 | biostudies-arrayexpress

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

Project description:This phase I trial studies the side effects and the best dose of alisertib when given together with vorinostat in treating patients with Hodgkin lymphoma, B-cell non-Hodgkin lymphoma, or peripheral T-cell lymphoma that has come back. Alisertib and vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

| 2123001 | ecrin-mdr-crc

Single Cell Genomic Analysis of Lymphoma

Project description:Single Cell Genomic Analysis of Lymphoma

| PRJNA671265 | ENA

Single Cell Genomic Analysis of Lymphoma

Project description:Single Cell Genomic Analysis of Lymphoma

| PRJNA671264 | ENA

Peripheral T-cell lymphoma: Molecular profiling recognizes subclasses and identifies prognostic markers

Project description:Peripheral T-cell lymphoma: Molecular profiling recognizes subclasses and identifies prognostic markers

| PRJNA757742 | ENA